SUBSTRATA MAIN PAGE


Bacillus infantis

RANK: Species

TAXONOMY: Terrabacteria group -> Firmicutes -> Bacilli -> Bacillales -> Bacillaceae -> Bacillus -> Bacillus infantis

OVERVIEW:

B. infantis is organotrophic aerobe that has the ability to metabolize D-xylose, galactose, glucose, fructose, mannitol, sorbitol, methyl a-D-glucoside, N-acetylglucosamine, amygdalin, arbutin, aesculin, salicin, maltose, melibiose, sucrose, trehalose, raffinose, starch, glycogen, gluconate, cellobiose, lactose and inulin. One study predicted the strain NRRL B-14911 to have over 321 possible metabolic pathways and 1088 different participating enzymes. As mentioned previously, the AAA strain of B. infantis has been shown to degrade azo dyes. The hypothalamus-pituitary-adrenal response is involved in the neurobiology of mood disorders and illnesses that include anxiety disorder, bipolar disorder, insomnia, posttraumatic stress disorder, borderline personality disorder, attention deficit-hyperactivity disorder (ADHD), major depressive disorder, burnout, chronic fatigue syndrome, fibromyalgia, irritable bowel syndrome, and alcoholism. The normalization of this response, as well as increased angiogenesis, is correlated with increased numbers of Bacillus infantis.

This species has been identified as a resident in the human gastrointestinal tract based on the phylogenetic framework of its small subunit ribosomal RNA gene sequences.[PMC 4262072]

COGEM
COGEM released a comprehensive database of pathogenicity assessment of around 2575 bacterial species in 2011. The database ranks the pathogenicity of species on a scale of 1 to 4. Bacillus infantis ranks on this scale:


TAGS
Keystone
Core species
Type species
Pathogen
Dysbiosis associated
Flora/ commensal
Gut associated
Probiotic
Leanness
Obesity
Skin microbiome
Fecal distribution
Oral microbiome
Vaginal microbiome
Butyrate producer
Catalase producer
Histamine producer
Food fermenter
Amylolytic
Propionate producer
Nitrifying
Biofilm producer
INTERACTIONS
KEGG PATHWAYS

CLUSTERS WITH
METABOLOMICS       
ANTIBIOTIC RESISTANCE   BIOFILM FORMERS   COGEM PATHOGENICITY   

SUBSTRATA ™ IS A REGISTERED TRADEMARK ® OF DATAPUNK BIOINFORMATICS, LLC. COPYRIGHT © 2015, 2016, 2017, 2018, 2019 ALL RIGHTS RESERVED.    |    DEVELOPER BLOG     |